Join the Sustainable HIV Prevention Initiative and partners for a webinar, “At a Crossroads: Reimagi...
Event Details
The Communities Delegation to the Unitaid Board represents the voices of people living with and affected by HIV, tuberculosis, malaria, and other global health challenges. The Delegation ensures that the perspectives of communities most impacted by diseases are reflected in Unitaid’s governance, strategies, and investments.
Every story reflects resilience, innovation, and hope. These lived experiences remind us why community voices matter.
TB care still misses vulnerable groups due to stigma, access gaps, and weak systems. Experts highlight how inclusive approaches and innovation can ens...
Ending TB requires more than innovation—communities drive trust, access, and care. Unitaid’s investments empower them to lead the fight against TB eff...
A Ukrainian health advocate shares her refugee journey in Germany, highlighting barriers to HIV and TB treatment and the vital role of community-led s...
From awareness walks to storytelling nights, our events shine a light on resilience, celebrate milestones, and unite communities in hope and joy.
Join the Sustainable HIV Prevention Initiative and partners for a webinar, “At a Crossroads: Reimagi...
Event Details
Join the Diagnostics Equity Consortium (DEC) for the second session of a two-part Study Club Series...
Event Details
Despite progress over the past two decades, maternal and newborn health outcomes remain uneven, with...
Event DetailsStay informed with the latest news, project highlights, and advocacy updates from our organization. Discover how we’re creating lasting change in the communities we serve.
South Africa launches an initiative to enable local production of lenacapavir, a long-acting HIV prevention drug, strengthening regional manufacturing...
Read MoreLa Delegación de Comunidades participó en la EB48 de Unitaid en Tokio, impulsando el compromiso comunitario y reformas clave.
Read MoreДелегация сообществ на 48-й сессии Совета ЮНИТЭЙД (Токио, дек. 2025): Одобрен CCSE с пилотами (Ленакапавир); оценка усиливает раннее вовлечение. Новый...
Read More